

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 5.72958186 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.58574738 |
| 3 | immunoglobulin mediated immune response (GO:0016064) | 5.45832220 |
| 4 | cytidine deamination (GO:0009972) | 5.42179551 |
| 5 | cytidine metabolic process (GO:0046087) | 5.42179551 |
| 6 | cytidine catabolic process (GO:0006216) | 5.42179551 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.15015524 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.00593564 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 5.00593564 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 5.00593564 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 5.00593564 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.00593564 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.00593564 |
| 14 | cellular response to zinc ion (GO:0071294) | 4.84913442 |
| 15 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.71460602 |
| 16 | positive regulation of interferon-alpha production (GO:0032727) | 4.61105720 |
| 17 | respiratory burst (GO:0045730) | 4.45572846 |
| 18 | regulation of interferon-alpha production (GO:0032647) | 4.32871393 |
| 19 | positive regulation of type 2 immune response (GO:0002830) | 4.27377293 |
| 20 | granulocyte activation (GO:0036230) | 4.19706043 |
| 21 | B cell mediated immunity (GO:0019724) | 4.19090995 |
| 22 | neutrophil activation (GO:0042119) | 4.18087891 |
| 23 | fucose catabolic process (GO:0019317) | 4.14694612 |
| 24 | L-fucose metabolic process (GO:0042354) | 4.14694612 |
| 25 | L-fucose catabolic process (GO:0042355) | 4.14694612 |
| 26 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.13329319 |
| 27 | cellular response to exogenous dsRNA (GO:0071360) | 4.11738247 |
| 28 | macrophage activation involved in immune response (GO:0002281) | 4.11540019 |
| 29 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.03367510 |
| 30 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.03117593 |
| 31 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.02599388 |
| 32 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 4.00099058 |
| 33 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.98351620 |
| 34 | negative regulation of cell killing (GO:0031342) | 3.98351620 |
| 35 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.95755104 |
| 36 | response to peptidoglycan (GO:0032494) | 3.93718466 |
| 37 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.91083620 |
| 38 | natural killer cell mediated immunity (GO:0002228) | 3.89911190 |
| 39 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.89911190 |
| 40 | activated T cell proliferation (GO:0050798) | 3.88431694 |
| 41 | regulation of gamma-delta T cell activation (GO:0046643) | 3.84037270 |
| 42 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.83664312 |
| 43 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.82259145 |
| 44 | B cell receptor signaling pathway (GO:0050853) | 3.80793684 |
| 45 | positive regulation of antigen processing and presentation (GO:0002579) | 3.80786326 |
| 46 | cellular response to type I interferon (GO:0071357) | 3.76306203 |
| 47 | type I interferon signaling pathway (GO:0060337) | 3.76306203 |
| 48 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.74905731 |
| 49 | positive regulation of mast cell activation (GO:0033005) | 3.73229466 |
| 50 | response to type I interferon (GO:0034340) | 3.71738281 |
| 51 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.69941273 |
| 52 | positive regulation of mast cell degranulation (GO:0043306) | 3.69941273 |
| 53 | positive regulation of macrophage cytokine production (GO:0060907) | 3.69262813 |
| 54 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.67698674 |
| 55 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.65101255 |
| 56 | germinal center formation (GO:0002467) | 3.64773610 |
| 57 | behavioral response to nicotine (GO:0035095) | 3.61717648 |
| 58 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.60666930 |
| 59 | regulation of B cell differentiation (GO:0045577) | 3.58062967 |
| 60 | cellular response to interferon-beta (GO:0035458) | 3.55483310 |
| 61 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.54302357 |
| 62 | cellular response to interferon-alpha (GO:0035457) | 3.52833784 |
| 63 | myeloid cell activation involved in immune response (GO:0002275) | 3.52492171 |
| 64 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.51607727 |
| 65 | leukocyte aggregation (GO:0070486) | 3.51353822 |
| 66 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.51106157 |
| 67 | positive regulation of defense response to virus by host (GO:0002230) | 3.49347100 |
| 68 | regulation of RIG-I signaling pathway (GO:0039535) | 3.49323288 |
| 69 | microglial cell activation (GO:0001774) | 3.48537831 |
| 70 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.46667196 |
| 71 | myeloid dendritic cell differentiation (GO:0043011) | 3.46182348 |
| 72 | DNA deamination (GO:0045006) | 3.42661997 |
| 73 | response to host immune response (GO:0052572) | 3.41906506 |
| 74 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.41906506 |
| 75 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.41101328 |
| 76 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.40343642 |
| 77 | defense response to protozoan (GO:0042832) | 3.39999077 |
| 78 | detection of bacterium (GO:0016045) | 3.38873682 |
| 79 | T-helper 1 type immune response (GO:0042088) | 3.38430124 |
| 80 | detection of other organism (GO:0098543) | 3.37394287 |
| 81 | leukocyte mediated cytotoxicity (GO:0001909) | 3.37127145 |
| 82 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.36679665 |
| 83 | negative thymic T cell selection (GO:0045060) | 3.34793313 |
| 84 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.34742638 |
| 85 | myeloid dendritic cell activation (GO:0001773) | 3.31677749 |
| 86 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.31103183 |
| 87 | mast cell activation (GO:0045576) | 3.28936634 |
| 88 | negative regulation of T cell mediated immunity (GO:0002710) | 3.27036235 |
| 89 | positive regulation of interferon-beta production (GO:0032728) | 3.25801751 |
| 90 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.25446323 |
| 91 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.25405549 |
| 92 | negative regulation of interleukin-12 production (GO:0032695) | 3.22975502 |
| 93 | negative T cell selection (GO:0043383) | 3.22239527 |
| 94 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.22016612 |
| 95 | regulation of antigen processing and presentation (GO:0002577) | 3.20897025 |
| 96 | interferon-gamma production (GO:0032609) | 3.18873876 |
| 97 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.17586188 |
| 98 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.17553130 |
| 99 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.16402267 |
| 100 | macrophage activation (GO:0042116) | 3.16141655 |
| 101 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.15980013 |
| 102 | regulation of type 2 immune response (GO:0002828) | 3.15081124 |
| 103 | reactive oxygen species biosynthetic process (GO:1903409) | 3.14976304 |
| 104 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.14654487 |
| 105 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.12718797 |
| 106 | positive regulation of B cell differentiation (GO:0045579) | 3.09617947 |
| 107 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.08365212 |
| 108 | positive regulation of cytokine biosynthetic process (GO:0042108) | 3.06028470 |
| 109 | myeloid leukocyte activation (GO:0002274) | 3.05595597 |
| 110 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.05530523 |
| 111 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.05175399 |
| 112 | positive regulation of interleukin-12 production (GO:0032735) | 3.03515278 |
| 113 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.03356369 |
| 114 | lymphocyte mediated immunity (GO:0002449) | 3.03282217 |
| 115 | cellular extravasation (GO:0045123) | 3.01275811 |
| 116 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.01150128 |
| 117 | response to interferon-alpha (GO:0035455) | 3.00261430 |
| 118 | superoxide anion generation (GO:0042554) | 2.99806766 |
| 119 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.99653327 |
| 120 | regulation of mast cell activation (GO:0033003) | 2.99396491 |
| 121 | detection of molecule of bacterial origin (GO:0032490) | 2.98430557 |
| 122 | response to host (GO:0075136) | 2.97847944 |
| 123 | response to host defenses (GO:0052200) | 2.97847944 |
| 124 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.97847944 |
| 125 | response to protozoan (GO:0001562) | 2.97635377 |
| 126 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.95319353 |
| 127 | positive regulation of B cell proliferation (GO:0030890) | 2.94167987 |
| 128 | positive thymic T cell selection (GO:0045059) | 2.92468102 |
| 129 | regulation of mast cell degranulation (GO:0043304) | 2.87271453 |
| 130 | cellular response to interleukin-15 (GO:0071350) | 2.84743519 |
| 131 | regulation of hypersensitivity (GO:0002883) | 2.84344080 |
| 132 | T cell costimulation (GO:0031295) | 2.83215912 |
| 133 | tolerance induction (GO:0002507) | 2.82445408 |
| 134 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.81077426 |
| 135 | positive regulation of B cell mediated immunity (GO:0002714) | 2.81077426 |
| 136 | T cell migration (GO:0072678) | 2.80407668 |
| 137 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.79908473 |
| 138 | negative regulation of mast cell activation (GO:0033004) | 2.79881496 |
| 139 | detection of external biotic stimulus (GO:0098581) | 2.79726055 |
| 140 | lymphocyte costimulation (GO:0031294) | 2.79417409 |
| 141 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.78732028 |
| 142 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.77517189 |
| 143 | regulation of memory T cell differentiation (GO:0043380) | 2.77228891 |
| 144 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.70774470 |
| 145 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.70018550 |
| 146 | cellular response to interferon-gamma (GO:0071346) | 2.67152645 |
| 147 | regulation of germinal center formation (GO:0002634) | 2.66884696 |
| 148 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.65686355 |
| 149 | response to interleukin-15 (GO:0070672) | 2.65214428 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 8.98197592 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.56451620 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.35033336 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.36664835 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.78978306 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.38350419 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.29738399 |
| 8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.55021454 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.47605557 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.24990768 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.24582285 |
| 12 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.05392860 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.97929943 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.89405727 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.84222044 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.83688684 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.73779842 |
| 18 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.70495843 |
| 19 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.40727953 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.37606700 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.33006099 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.18660828 |
| 23 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.16970557 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 1.92053312 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.85519519 |
| 26 | VDR_22108803_ChIP-Seq_LS180_Human | 1.74200388 |
| 27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73025317 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.72494516 |
| 29 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.70529851 |
| 30 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.69239961 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 1.67329504 |
| 32 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.66872304 |
| 33 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.66869693 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.60625182 |
| 35 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.59536550 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.57757217 |
| 37 | MYB_26560356_Chip-Seq_TH1_Human | 1.54761077 |
| 38 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53073786 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.50904779 |
| 40 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.48451744 |
| 41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.47166702 |
| 42 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.46553804 |
| 43 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.45012830 |
| 44 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.42870801 |
| 45 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42786518 |
| 46 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.42499777 |
| 47 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.42242923 |
| 48 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.40652127 |
| 49 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.40480424 |
| 50 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.40363019 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38991773 |
| 52 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.36098487 |
| 53 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.35282499 |
| 54 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.35162917 |
| 55 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33571233 |
| 56 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.31952539 |
| 57 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.31820069 |
| 58 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.30177996 |
| 59 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.29872550 |
| 60 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.29010324 |
| 61 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.25871073 |
| 62 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.25129451 |
| 63 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.25124905 |
| 64 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.22535293 |
| 65 | ERA_21632823_ChIP-Seq_H3396_Human | 1.20938854 |
| 66 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20127694 |
| 67 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.19794377 |
| 68 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18222576 |
| 69 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.17294437 |
| 70 | GATA3_26560356_Chip-Seq_TH2_Human | 1.15195601 |
| 71 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13178550 |
| 72 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.12175758 |
| 73 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.10303224 |
| 74 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.09896102 |
| 75 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.09795737 |
| 76 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08635455 |
| 77 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.07977801 |
| 78 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07490923 |
| 79 | UTX_26944678_Chip-Seq_JUKART_Human | 1.06971217 |
| 80 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.05878688 |
| 81 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05216398 |
| 82 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.04492449 |
| 83 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.04492449 |
| 84 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04371669 |
| 85 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04362566 |
| 86 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.03573992 |
| 87 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.03507378 |
| 88 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.03008842 |
| 89 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.02875555 |
| 90 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.01324439 |
| 91 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01228998 |
| 92 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00655072 |
| 93 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00506404 |
| 94 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.00036621 |
| 95 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99404527 |
| 96 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98712520 |
| 97 | GATA1_22025678_ChIP-Seq_K562_Human | 0.98417149 |
| 98 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.97921530 |
| 99 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.97021133 |
| 100 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.95325100 |
| 101 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95092661 |
| 102 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.94927458 |
| 103 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.94844980 |
| 104 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.94522323 |
| 105 | MYC_22102868_ChIP-Seq_BL_Human | 0.93999976 |
| 106 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.93678416 |
| 107 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93090896 |
| 108 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92934304 |
| 109 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.92934304 |
| 110 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.92252273 |
| 111 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.91445229 |
| 112 | MAF_26560356_Chip-Seq_TH2_Human | 0.89933204 |
| 113 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89904706 |
| 114 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.89244722 |
| 115 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.88718204 |
| 116 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.87319867 |
| 117 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.87319867 |
| 118 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.87151493 |
| 119 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.86430829 |
| 120 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.80496989 |
| 121 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77466340 |
| 122 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.65309389 |
| 123 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.64743052 |
| 124 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.64206682 |
| 125 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.63801256 |
| 126 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.62631532 |
| 127 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.62474842 |
| 128 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.61259840 |
| 129 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.60949019 |
| 130 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.60317691 |
| 131 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.58290805 |
| 132 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.57900320 |
| 133 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.57128578 |
| 134 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.57120477 |
| 135 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.52758587 |
| 136 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.52649225 |
| 137 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.52293689 |
| 138 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.51414482 |
| 139 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.50467167 |
| 140 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.50204970 |
| 141 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.49834724 |
| 142 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.49444520 |
| 143 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.49108231 |
| 144 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.47322189 |
| 145 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.47093744 |
| 146 | GATA3_26560356_Chip-Seq_TH1_Human | 0.46857012 |
| 147 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.46798484 |
| 148 | P300_27268052_Chip-Seq_Bcells_Human | 0.45306710 |
| 149 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.45271521 |
| 150 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.44632500 |
| 151 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.44473777 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 6.00221414 |
| 2 | MP0002148_abnormal_hypersensitivity_rea | 4.08844595 |
| 3 | MP0009785_altered_susceptibility_to | 3.78621005 |
| 4 | MP0001790_abnormal_immune_system | 3.71520137 |
| 5 | MP0005387_immune_system_phenotype | 3.71520137 |
| 6 | MP0005671_abnormal_response_to | 3.71254267 |
| 7 | MP0003436_decreased_susceptibility_to | 3.67980827 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.66794702 |
| 9 | MP0000685_abnormal_immune_system | 3.44616111 |
| 10 | MP0001800_abnormal_humoral_immune | 3.43912399 |
| 11 | MP0005025_abnormal_response_to | 3.20141960 |
| 12 | MP0003724_increased_susceptibility_to | 3.19835939 |
| 13 | MP0002452_abnormal_antigen_presenting | 3.18567618 |
| 14 | MP0002419_abnormal_innate_immunity | 3.17535728 |
| 15 | MP0006082_CNS_inflammation | 3.16044118 |
| 16 | MP0003303_peritoneal_inflammation | 3.12666118 |
| 17 | MP0002723_abnormal_immune_serum | 3.00127767 |
| 18 | MP0001986_abnormal_taste_sensitivity | 2.83091664 |
| 19 | MP0001853_heart_inflammation | 2.73811376 |
| 20 | MP0001819_abnormal_immune_cell | 2.67826914 |
| 21 | MP0004510_myositis | 2.67620453 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.66080446 |
| 23 | MP0000569_abnormal_digit_pigmentation | 2.11059546 |
| 24 | MP0002405_respiratory_system_inflammati | 2.08523080 |
| 25 | MP0009764_decreased_sensitivity_to | 2.02452354 |
| 26 | MP0001845_abnormal_inflammatory_respons | 1.98696775 |
| 27 | MP0000716_abnormal_immune_system | 1.97437218 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.90957546 |
| 29 | MP0002398_abnormal_bone_marrow | 1.90937980 |
| 30 | MP0005310_abnormal_salivary_gland | 1.89415304 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.73462813 |
| 32 | MP0008469_abnormal_protein_level | 1.71210340 |
| 33 | MP0004947_skin_inflammation | 1.70176517 |
| 34 | MP0008875_abnormal_xenobiotic_pharmacok | 1.69657359 |
| 35 | MP0002006_tumorigenesis | 1.69354057 |
| 36 | MP0003448_altered_tumor_morphology | 1.69343787 |
| 37 | MP0003136_yellow_coat_color | 1.66238129 |
| 38 | MP0000689_abnormal_spleen_morphology | 1.63936476 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.61996735 |
| 40 | MP0002429_abnormal_blood_cell | 1.56756745 |
| 41 | MP0001873_stomach_inflammation | 1.55623436 |
| 42 | MP0009333_abnormal_splenocyte_physiolog | 1.49613174 |
| 43 | MP0002722_abnormal_immune_system | 1.45830581 |
| 44 | MP0005058_abnormal_lysosome_morphology | 1.42601809 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.42405643 |
| 46 | MP0003075_altered_response_to | 1.42383649 |
| 47 | MP0004381_abnormal_hair_follicle | 1.38585053 |
| 48 | MP0000343_altered_response_to | 1.38571576 |
| 49 | MP0005645_abnormal_hypothalamus_physiol | 1.37702759 |
| 50 | MP0000858_altered_metastatic_potential | 1.37475741 |
| 51 | MP0008872_abnormal_physiological_respon | 1.34739939 |
| 52 | MP0003763_abnormal_thymus_physiology | 1.31811415 |
| 53 | MP0008877_abnormal_DNA_methylation | 1.31439389 |
| 54 | MP0004782_abnormal_surfactant_physiolog | 1.27462161 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.23006187 |
| 56 | MP0002166_altered_tumor_susceptibility | 1.22111209 |
| 57 | MP0005075_abnormal_melanosome_morpholog | 1.19306661 |
| 58 | MP0004142_abnormal_muscle_tone | 1.17079912 |
| 59 | MP0009840_abnormal_foam_cell | 1.15649470 |
| 60 | MP0002933_joint_inflammation | 1.14423346 |
| 61 | MP0003011_delayed_dark_adaptation | 1.12795068 |
| 62 | MP0004742_abnormal_vestibular_system | 1.12374703 |
| 63 | MP0005166_decreased_susceptibility_to | 1.12356568 |
| 64 | MP0001663_abnormal_digestive_system | 1.12194139 |
| 65 | MP0002928_abnormal_bile_duct | 1.11605746 |
| 66 | MP0002653_abnormal_ependyma_morphology | 1.10173130 |
| 67 | MP0001968_abnormal_touch/_nociception | 1.09153313 |
| 68 | MP0003646_muscle_fatigue | 1.09062810 |
| 69 | MP0005084_abnormal_gallbladder_morpholo | 1.06671113 |
| 70 | MP0000015_abnormal_ear_pigmentation | 1.06632935 |
| 71 | MP0009763_increased_sensitivity_to | 1.01073116 |
| 72 | MP0005451_abnormal_body_composition | 1.01035939 |
| 73 | MP0003186_abnormal_redox_activity | 0.99997737 |
| 74 | MP0003183_abnormal_peptide_metabolism | 0.99324921 |
| 75 | MP0000372_irregular_coat_pigmentation | 0.99148426 |
| 76 | MP0002163_abnormal_gland_morphology | 0.97416940 |
| 77 | MP0005551_abnormal_eye_electrophysiolog | 0.90573071 |
| 78 | MP0009046_muscle_twitch | 0.89755403 |
| 79 | MP0002102_abnormal_ear_morphology | 0.86368772 |
| 80 | MP0004043_abnormal_pH_regulation | 0.85836543 |
| 81 | MP0003195_calcinosis | 0.84913202 |
| 82 | MP0000604_amyloidosis | 0.84148364 |
| 83 | MP0005167_abnormal_blood-brain_barrier | 0.83911579 |
| 84 | MP0003690_abnormal_glial_cell | 0.83846664 |
| 85 | MP0003806_abnormal_nucleotide_metabolis | 0.82922330 |
| 86 | MP0003172_abnormal_lysosome_physiology | 0.82267708 |
| 87 | MP0009745_abnormal_behavioral_response | 0.80667477 |
| 88 | MP0003300_gastrointestinal_ulcer | 0.79799723 |
| 89 | MP0005390_skeleton_phenotype | 0.78561850 |
| 90 | MP0003866_abnormal_defecation | 0.77118525 |
| 91 | MP0001545_abnormal_hematopoietic_system | 0.76854378 |
| 92 | MP0005397_hematopoietic_system_phenotyp | 0.76854378 |
| 93 | MP0005164_abnormal_response_to | 0.76408285 |
| 94 | MP0002638_abnormal_pupillary_reflex | 0.74341157 |
| 95 | MP0003252_abnormal_bile_duct | 0.73915124 |
| 96 | MP0004130_abnormal_muscle_cell | 0.72514036 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.72215246 |
| 98 | MP0003828_pulmonary_edema | 0.71315124 |
| 99 | MP0002138_abnormal_hepatobiliary_system | 0.70746378 |
| 100 | MP0002277_abnormal_respiratory_mucosa | 0.69873899 |
| 101 | MP0002132_abnormal_respiratory_system | 0.69111881 |
| 102 | MP0001919_abnormal_reproductive_system | 0.68674359 |
| 103 | MP0000703_abnormal_thymus_morphology | 0.68396020 |
| 104 | MP0008961_abnormal_basal_metabolism | 0.65265785 |
| 105 | MP0000249_abnormal_blood_vessel | 0.64192169 |
| 106 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.64072391 |
| 107 | MP0010307_abnormal_tumor_latency | 0.64058178 |
| 108 | MP0002095_abnormal_skin_pigmentation | 0.62728385 |
| 109 | MP0002019_abnormal_tumor_incidence | 0.62067788 |
| 110 | MP0004883_abnormal_blood_vessel | 0.61789810 |
| 111 | MP0010386_abnormal_urinary_bladder | 0.61693701 |
| 112 | MP0002735_abnormal_chemical_nociception | 0.60632181 |
| 113 | MP0009278_abnormal_bone_marrow | 0.60239202 |
| 114 | MP0005381_digestive/alimentary_phenotyp | 0.57660466 |
| 115 | MP0001501_abnormal_sleep_pattern | 0.57146870 |
| 116 | MP0005379_endocrine/exocrine_gland_phen | 0.56696353 |
| 117 | MP0000920_abnormal_myelination | 0.55556614 |
| 118 | MP0003045_fibrosis | 0.54816805 |
| 119 | MP0002693_abnormal_pancreas_physiology | 0.54708680 |
| 120 | MP0000470_abnormal_stomach_morphology | 0.54699006 |
| 121 | MP0001851_eye_inflammation | 0.54433988 |
| 122 | MP0000230_abnormal_systemic_arterial | 0.53142752 |
| 123 | MP0005423_abnormal_somatic_nervous | 0.53013496 |
| 124 | MP0005253_abnormal_eye_physiology | 0.52208482 |
| 125 | MP0003795_abnormal_bone_structure | 0.51533181 |
| 126 | MP0000609_abnormal_liver_physiology | 0.49575381 |
| 127 | MP0005076_abnormal_cell_differentiation | 0.49073320 |
| 128 | MP0001958_emphysema | 0.48667225 |
| 129 | MP0003566_abnormal_cell_adhesion | 0.48166731 |
| 130 | MP0003656_abnormal_erythrocyte_physiolo | 0.48051846 |
| 131 | MP0000465_gastrointestinal_hemorrhage | 0.47696825 |
| 132 | MP0001191_abnormal_skin_condition | 0.47451607 |
| 133 | MP0008873_increased_physiological_sensi | 0.46805721 |
| 134 | MP0003453_abnormal_keratinocyte_physiol | 0.46285955 |
| 135 | MP0005319_abnormal_enzyme/_coenzyme | 0.45141270 |
| 136 | MP0004808_abnormal_hematopoietic_stem | 0.44684436 |
| 137 | MP0003091_abnormal_cell_migration | 0.44049400 |
| 138 | MP0009643_abnormal_urine_homeostasis | 0.43888517 |
| 139 | MP0000371_diluted_coat_color | 0.41333138 |
| 140 | MP0005174_abnormal_tail_pigmentation | 0.40931692 |
| 141 | MP0008260_abnormal_autophagy | 0.40768199 |
| 142 | MP0000767_abnormal_smooth_muscle | 0.39634679 |
| 143 | MP0003279_aneurysm | 0.39341031 |
| 144 | MP0009765_abnormal_xenobiotic_induced | 0.37973700 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.56890150 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.91550134 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.63452298 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.12195065 |
| 5 | Mediastinal lymphadenopathy (HP:0100721) | 5.30005684 |
| 6 | Autoimmune thrombocytopenia (HP:0001973) | 4.99622715 |
| 7 | Agammaglobulinemia (HP:0004432) | 4.76258996 |
| 8 | Recurrent skin infections (HP:0001581) | 4.62877849 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.59731059 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.58067575 |
| 11 | Stomatitis (HP:0010280) | 4.56852037 |
| 12 | Obstructive lung disease (HP:0006536) | 4.34941892 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 4.34941892 |
| 14 | Gingivitis (HP:0000230) | 4.34103833 |
| 15 | Vasculitis (HP:0002633) | 4.26469492 |
| 16 | Recurrent fungal infections (HP:0002841) | 4.13367075 |
| 17 | Systemic lupus erythematosus (HP:0002725) | 4.11748720 |
| 18 | Cellulitis (HP:0100658) | 4.07606751 |
| 19 | Meningitis (HP:0001287) | 4.05625758 |
| 20 | Increased IgM level (HP:0003496) | 4.01813712 |
| 21 | Gastrointestinal stroma tumor (HP:0100723) | 3.94213940 |
| 22 | Myositis (HP:0100614) | 3.88569432 |
| 23 | Recurrent cutaneous fungal infections (HP:0011370) | 3.82901584 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.82901584 |
| 25 | Recurrent bronchitis (HP:0002837) | 3.75379980 |
| 26 | Interstitial pulmonary disease (HP:0006530) | 3.74654283 |
| 27 | Recurrent lower respiratory tract infections (HP:0002783) | 3.67682120 |
| 28 | Retrobulbar optic neuritis (HP:0100654) | 3.66086873 |
| 29 | Optic neuritis (HP:0100653) | 3.66086873 |
| 30 | Recurrent pneumonia (HP:0006532) | 3.62929504 |
| 31 | Recurrent sinusitis (HP:0011108) | 3.58846324 |
| 32 | Recurrent viral infections (HP:0004429) | 3.54722891 |
| 33 | Basal ganglia calcification (HP:0002135) | 3.54305525 |
| 34 | Orchitis (HP:0100796) | 3.41895899 |
| 35 | IgA deficiency (HP:0002720) | 3.33764709 |
| 36 | Vacuolated lymphocytes (HP:0001922) | 3.21229751 |
| 37 | IgG deficiency (HP:0004315) | 3.16628514 |
| 38 | Congenital stationary night blindness (HP:0007642) | 3.11893824 |
| 39 | Osteomyelitis (HP:0002754) | 3.08662620 |
| 40 | Hypergammaglobulinemia (HP:0010702) | 3.05537279 |
| 41 | Lymphopenia (HP:0001888) | 2.94805602 |
| 42 | Pustule (HP:0200039) | 2.93795516 |
| 43 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.92456558 |
| 44 | Abnormality of midbrain morphology (HP:0002418) | 2.89188237 |
| 45 | Molar tooth sign on MRI (HP:0002419) | 2.89188237 |
| 46 | Colitis (HP:0002583) | 2.87513327 |
| 47 | Urticaria (HP:0001025) | 2.86659317 |
| 48 | Periodontitis (HP:0000704) | 2.83090272 |
| 49 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.78465274 |
| 50 | Pancreatic cysts (HP:0001737) | 2.77687169 |
| 51 | Emphysema (HP:0002097) | 2.77211313 |
| 52 | Pulmonary infiltrates (HP:0002113) | 2.75582788 |
| 53 | Thyroiditis (HP:0100646) | 2.75107414 |
| 54 | Inability to walk (HP:0002540) | 2.74850508 |
| 55 | Abnormality of T cell number (HP:0011839) | 2.73279185 |
| 56 | IgM deficiency (HP:0002850) | 2.68711236 |
| 57 | Glomerulonephritis (HP:0000099) | 2.66984964 |
| 58 | Sepsis (HP:0100806) | 2.66159704 |
| 59 | Combined immunodeficiency (HP:0005387) | 2.62476339 |
| 60 | Attenuation of retinal blood vessels (HP:0007843) | 2.61100087 |
| 61 | Chronic otitis media (HP:0000389) | 2.59590401 |
| 62 | Poor head control (HP:0002421) | 2.55982433 |
| 63 | Increased cerebral lipofuscin (HP:0011813) | 2.55760814 |
| 64 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.53022408 |
| 65 | Chronic sinusitis (HP:0011109) | 2.52802461 |
| 66 | Restrictive lung disease (HP:0002091) | 2.47419519 |
| 67 | Myocardial infarction (HP:0001658) | 2.45984068 |
| 68 | Inflammation of the large intestine (HP:0002037) | 2.45621167 |
| 69 | Thick nail (HP:0001805) | 2.45152058 |
| 70 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.45028987 |
| 71 | Joint hemorrhage (HP:0005261) | 2.44843044 |
| 72 | Leukocytosis (HP:0001974) | 2.43087240 |
| 73 | Petechiae (HP:0000967) | 2.42751778 |
| 74 | Hemoptysis (HP:0002105) | 2.40844826 |
| 75 | T lymphocytopenia (HP:0005403) | 2.40227249 |
| 76 | Abnormality of T cells (HP:0002843) | 2.37624200 |
| 77 | Abnormality of the prostate (HP:0008775) | 2.36932292 |
| 78 | Keratoconjunctivitis sicca (HP:0001097) | 2.36146559 |
| 79 | Nephritis (HP:0000123) | 2.36081319 |
| 80 | Arterial thrombosis (HP:0004420) | 2.35110877 |
| 81 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.34479600 |
| 82 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.34479600 |
| 83 | Abnormality of glycolipid metabolism (HP:0010969) | 2.34479600 |
| 84 | Gingival bleeding (HP:0000225) | 2.33242329 |
| 85 | Clumsiness (HP:0002312) | 2.31897527 |
| 86 | Axonal loss (HP:0003447) | 2.31346501 |
| 87 | Hypochromic anemia (HP:0001931) | 2.31214027 |
| 88 | Concave nail (HP:0001598) | 2.28987347 |
| 89 | Gastrointestinal inflammation (HP:0004386) | 2.27484664 |
| 90 | Stomach cancer (HP:0012126) | 2.25106246 |
| 91 | Disinhibition (HP:0000734) | 2.24218215 |
| 92 | Gastrointestinal infarctions (HP:0005244) | 2.24127336 |
| 93 | Encephalitis (HP:0002383) | 2.22490985 |
| 94 | Chronic diarrhea (HP:0002028) | 2.22386370 |
| 95 | Tubular atrophy (HP:0000092) | 2.22112958 |
| 96 | Purpura (HP:0000979) | 2.21638617 |
| 97 | Abnormality of T cell physiology (HP:0011840) | 2.21503489 |
| 98 | True hermaphroditism (HP:0010459) | 2.21213118 |
| 99 | Absent/shortened dynein arms (HP:0200106) | 2.18833250 |
| 100 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.18833250 |
| 101 | Arthralgia (HP:0002829) | 2.18134676 |
| 102 | Cheilitis (HP:0100825) | 2.16240650 |
| 103 | Severe combined immunodeficiency (HP:0004430) | 2.15361099 |
| 104 | Autoimmune hemolytic anemia (HP:0001890) | 2.14446923 |
| 105 | Abnormality of the pleura (HP:0002103) | 2.13874998 |
| 106 | Keratoconjunctivitis (HP:0001096) | 2.13798885 |
| 107 | Mutism (HP:0002300) | 2.12912114 |
| 108 | Skin ulcer (HP:0200042) | 2.12403412 |
| 109 | Birth length less than 3rd percentile (HP:0003561) | 2.11949915 |
| 110 | Decreased central vision (HP:0007663) | 2.11338541 |
| 111 | Pancreatic fibrosis (HP:0100732) | 2.11100419 |
| 112 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.10896063 |
| 113 | Agnosia (HP:0010524) | 2.09406900 |
| 114 | Skin rash (HP:0000988) | 2.08078187 |
| 115 | Abnormality of complement system (HP:0005339) | 2.07275049 |
| 116 | Prostate neoplasm (HP:0100787) | 2.07169460 |
| 117 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.05387921 |
| 118 | Abnormality of alanine metabolism (HP:0010916) | 2.05387921 |
| 119 | Hyperalaninemia (HP:0003348) | 2.05387921 |
| 120 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.03619801 |
| 121 | Abolished electroretinogram (ERG) (HP:0000550) | 2.01706020 |
| 122 | Nephronophthisis (HP:0000090) | 2.00406156 |
| 123 | Abnormality of eosinophils (HP:0001879) | 2.00331253 |
| 124 | Leukopenia (HP:0001882) | 1.97684118 |
| 125 | Bronchitis (HP:0012387) | 1.97003982 |
| 126 | Congenital, generalized hypertrichosis (HP:0004540) | 1.95638281 |
| 127 | Eosinophilia (HP:0001880) | 1.94301347 |
| 128 | Panhypogammaglobulinemia (HP:0003139) | 1.93968071 |
| 129 | Polydipsia (HP:0001959) | 1.92738922 |
| 130 | Abnormal drinking behavior (HP:0030082) | 1.92738922 |
| 131 | Progressive inability to walk (HP:0002505) | 1.92394542 |
| 132 | Global brain atrophy (HP:0002283) | 1.91778864 |
| 133 | Anorexia (HP:0002039) | 1.90530901 |
| 134 | Chest pain (HP:0100749) | 1.89396363 |
| 135 | Large for gestational age (HP:0001520) | 1.85297150 |
| 136 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.85284122 |
| 137 | Chronic hepatic failure (HP:0100626) | 1.84683508 |
| 138 | Spontaneous hematomas (HP:0007420) | 1.82247676 |
| 139 | Hyperventilation (HP:0002883) | 1.81389992 |
| 140 | Type II lissencephaly (HP:0007260) | 1.79545355 |
| 141 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.77029198 |
| 142 | Neutropenia (HP:0001875) | 1.73699088 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 6.64237936 |
| 2 | PBK | 4.48823860 |
| 3 | MAP3K14 | 4.23904956 |
| 4 | RIPK4 | 4.15454995 |
| 5 | MAP4K1 | 3.63490575 |
| 6 | TLK1 | 3.17557204 |
| 7 | TYK2 | 2.97484213 |
| 8 | TBK1 | 2.90517915 |
| 9 | IRAK4 | 2.84726629 |
| 10 | FRK | 2.68043946 |
| 11 | IKBKB | 2.20547778 |
| 12 | SYK | 2.19144588 |
| 13 | IRAK3 | 2.16286333 |
| 14 | IKBKE | 2.13125818 |
| 15 | TXK | 2.10241889 |
| 16 | ZAK | 1.95123774 |
| 17 | JAK1 | 1.92097278 |
| 18 | MST4 | 1.91776111 |
| 19 | KIT | 1.91255483 |
| 20 | CSK | 1.88675007 |
| 21 | MAP3K13 | 1.85099968 |
| 22 | JAK3 | 1.84512456 |
| 23 | ZAP70 | 1.75222626 |
| 24 | NEK9 | 1.74122223 |
| 25 | WNK4 | 1.71451352 |
| 26 | LYN | 1.70565441 |
| 27 | ERN1 | 1.68789676 |
| 28 | ACVR1B | 1.62637265 |
| 29 | BMPR1B | 1.59751536 |
| 30 | BTK | 1.48605504 |
| 31 | BMPR2 | 1.36379959 |
| 32 | NME2 | 1.32204567 |
| 33 | CSF1R | 1.32042415 |
| 34 | PINK1 | 1.28791791 |
| 35 | CHUK | 1.24877410 |
| 36 | HCK | 1.24871230 |
| 37 | CAMKK2 | 1.23952867 |
| 38 | OXSR1 | 1.23273277 |
| 39 | PRKCQ | 1.18663637 |
| 40 | CDK19 | 1.17660176 |
| 41 | MAP3K10 | 1.13462431 |
| 42 | INSRR | 1.13447851 |
| 43 | TAOK3 | 1.08691805 |
| 44 | GRK7 | 1.08123855 |
| 45 | LCK | 1.04845081 |
| 46 | PIM2 | 1.03769928 |
| 47 | PRKCH | 1.00623682 |
| 48 | MAPK15 | 1.00246502 |
| 49 | STK10 | 0.98902443 |
| 50 | ADRBK1 | 0.97145293 |
| 51 | ABL2 | 0.96780707 |
| 52 | STK4 | 0.95822958 |
| 53 | RPS6KA4 | 0.95812296 |
| 54 | PIK3CA | 0.95410035 |
| 55 | CLK1 | 0.94901498 |
| 56 | MATK | 0.92257395 |
| 57 | GRK1 | 0.91768280 |
| 58 | JAK2 | 0.91602473 |
| 59 | RIPK1 | 0.89642549 |
| 60 | EPHB1 | 0.89172416 |
| 61 | FGR | 0.89008847 |
| 62 | MAPK13 | 0.88771514 |
| 63 | PTK2B | 0.88250251 |
| 64 | TEC | 0.85012012 |
| 65 | MARK3 | 0.82859483 |
| 66 | PRKCD | 0.82689984 |
| 67 | STK11 | 0.82054896 |
| 68 | TGFBR2 | 0.81783495 |
| 69 | CAMKK1 | 0.81324672 |
| 70 | PIM1 | 0.79854157 |
| 71 | WNK3 | 0.76477639 |
| 72 | GRK6 | 0.76213335 |
| 73 | SIK3 | 0.75891105 |
| 74 | EIF2AK2 | 0.74832054 |
| 75 | TGFBR1 | 0.74191151 |
| 76 | MAPK12 | 0.73294632 |
| 77 | MAP4K2 | 0.71217496 |
| 78 | PASK | 0.69464835 |
| 79 | RPS6KA5 | 0.69066804 |
| 80 | FGFR4 | 0.67868479 |
| 81 | ITK | 0.66062865 |
| 82 | MAP2K6 | 0.65696907 |
| 83 | WNK1 | 0.63557716 |
| 84 | KDR | 0.62636207 |
| 85 | ADRBK2 | 0.62594073 |
| 86 | FES | 0.62071227 |
| 87 | EIF2AK3 | 0.61636141 |
| 88 | MAP3K12 | 0.60066288 |
| 89 | EIF2AK1 | 0.58463287 |
| 90 | ABL1 | 0.58451394 |
| 91 | LRRK2 | 0.57482202 |
| 92 | BMX | 0.57204523 |
| 93 | FGFR3 | 0.57010238 |
| 94 | TESK1 | 0.55969150 |
| 95 | YES1 | 0.54356741 |
| 96 | IRAK1 | 0.48924403 |
| 97 | ERBB3 | 0.48594001 |
| 98 | FYN | 0.47046963 |
| 99 | MAP3K11 | 0.46114114 |
| 100 | MAPK7 | 0.44404361 |
| 101 | MAPKAPK3 | 0.41717405 |
| 102 | PDPK1 | 0.40938972 |
| 103 | PKN1 | 0.38574311 |
| 104 | EGFR | 0.37000432 |
| 105 | MST1R | 0.35701384 |
| 106 | CDC42BPA | 0.35546397 |
| 107 | MAP2K4 | 0.33272195 |
| 108 | PRKCI | 0.33256992 |
| 109 | SIK2 | 0.32387700 |
| 110 | IRAK2 | 0.30692092 |
| 111 | MAP2K2 | 0.30370511 |
| 112 | MAPK11 | 0.29398153 |
| 113 | MAP3K5 | 0.27880536 |
| 114 | VRK1 | 0.27556693 |
| 115 | MAPKAPK2 | 0.27283538 |
| 116 | INSR | 0.27134361 |
| 117 | ARAF | 0.26127636 |
| 118 | BCKDK | 0.25691837 |
| 119 | SGK2 | 0.25180958 |
| 120 | TRPM7 | 0.24204744 |
| 121 | STK24 | 0.24141539 |
| 122 | PAK3 | 0.23880469 |
| 123 | CAMK1 | 0.23871824 |
| 124 | PRKCE | 0.23627245 |
| 125 | CAMK4 | 0.23250339 |
| 126 | PRKCZ | 0.22919452 |
| 127 | EPHA3 | 0.22257828 |
| 128 | NTRK3 | 0.21652770 |
| 129 | IGF1R | 0.19736960 |
| 130 | PDK1 | 0.17424855 |
| 131 | ALK | 0.16274476 |
| 132 | MAP2K3 | 0.15842897 |
| 133 | PIK3CG | 0.15484028 |
| 134 | KSR2 | 0.13777933 |
| 135 | BCR | 0.12970276 |
| 136 | TESK2 | 0.11208025 |
| 137 | NUAK1 | 0.10182022 |
| 138 | TNK2 | 0.08474926 |
| 139 | RPS6KA6 | 0.07758017 |
| 140 | NLK | 0.07706607 |
| 141 | DAPK2 | 0.07542401 |
| 142 | SRC | 0.07131146 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.81501818 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.24622759 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.21719507 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.17882201 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.13466156 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.10781315 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.79353685 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.76933975 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.67597955 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.54565410 |
| 11 | Asthma_Homo sapiens_hsa05310 | 2.53603011 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.42179676 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.31988923 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 2.22211092 |
| 15 | Pertussis_Homo sapiens_hsa05133 | 2.12958644 |
| 16 | Legionellosis_Homo sapiens_hsa05134 | 2.10585630 |
| 17 | Measles_Homo sapiens_hsa05162 | 2.07393858 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.07049213 |
| 19 | Malaria_Homo sapiens_hsa05144 | 2.04015780 |
| 20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.02442195 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.99159555 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.95819535 |
| 23 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.85759319 |
| 24 | Salmonella infection_Homo sapiens_hsa05132 | 1.84724771 |
| 25 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.83429648 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.78276042 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.68645635 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.64533046 |
| 29 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.61214307 |
| 30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.59667901 |
| 31 | Phagosome_Homo sapiens_hsa04145 | 1.53966670 |
| 32 | Lysosome_Homo sapiens_hsa04142 | 1.53228919 |
| 33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.51752616 |
| 34 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.50589951 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.47295237 |
| 36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.44456718 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.39834338 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.37942294 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.36174287 |
| 40 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.35777332 |
| 41 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.35505224 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 1.31674444 |
| 43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.22010123 |
| 44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.11483355 |
| 45 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.03751449 |
| 46 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.03519131 |
| 47 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.03226135 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00717300 |
| 49 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.99847642 |
| 50 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.97817483 |
| 51 | Other glycan degradation_Homo sapiens_hsa00511 | 0.95661673 |
| 52 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.95132653 |
| 53 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.92223776 |
| 54 | Proteasome_Homo sapiens_hsa03050 | 0.87595009 |
| 55 | Phototransduction_Homo sapiens_hsa04744 | 0.86619518 |
| 56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.85452862 |
| 57 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.85342414 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.84996669 |
| 59 | Hepatitis B_Homo sapiens_hsa05161 | 0.81532237 |
| 60 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.75586336 |
| 61 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.74124865 |
| 62 | Hepatitis C_Homo sapiens_hsa05160 | 0.70252158 |
| 63 | ABC transporters_Homo sapiens_hsa02010 | 0.69425990 |
| 64 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.69160536 |
| 65 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.67484500 |
| 66 | Base excision repair_Homo sapiens_hsa03410 | 0.67228335 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.66920007 |
| 68 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.66501579 |
| 69 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.65701308 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.64127665 |
| 71 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63361499 |
| 72 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.63075209 |
| 73 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62292892 |
| 74 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.61047299 |
| 75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52137672 |
| 76 | Mismatch repair_Homo sapiens_hsa03430 | 0.51536077 |
| 77 | DNA replication_Homo sapiens_hsa03030 | 0.49839877 |
| 78 | Olfactory transduction_Homo sapiens_hsa04740 | 0.49571902 |
| 79 | Morphine addiction_Homo sapiens_hsa05032 | 0.49507349 |
| 80 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.48674367 |
| 81 | Platelet activation_Homo sapiens_hsa04611 | 0.45341792 |
| 82 | Amoebiasis_Homo sapiens_hsa05146 | 0.45295414 |
| 83 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.43930492 |
| 84 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.43508339 |
| 85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43286567 |
| 86 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.43146126 |
| 87 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.42501706 |
| 88 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.42140345 |
| 89 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.41143187 |
| 90 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.39612317 |
| 91 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.39563083 |
| 92 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38908365 |
| 93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.37569108 |
| 94 | Taste transduction_Homo sapiens_hsa04742 | 0.37398482 |
| 95 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.34648775 |
| 96 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34507210 |
| 97 | Homologous recombination_Homo sapiens_hsa03440 | 0.33846944 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32804310 |
| 99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32617782 |
| 100 | Ribosome_Homo sapiens_hsa03010 | 0.30348469 |
| 101 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.29613927 |
| 102 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.29163406 |
| 103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28756967 |
| 104 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28715823 |
| 105 | HTLV-I infection_Homo sapiens_hsa05166 | 0.27964266 |
| 106 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.27003033 |
| 107 | Nicotine addiction_Homo sapiens_hsa05033 | 0.26270352 |
| 108 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.26084381 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.25191315 |
| 110 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.23871245 |
| 111 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.23670402 |
| 112 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.23537733 |
| 113 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.22161995 |
| 114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21768733 |
| 115 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.21633241 |
| 116 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.20887998 |
| 117 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.20304635 |
| 118 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.20065697 |
| 119 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.20032863 |
| 120 | Basal transcription factors_Homo sapiens_hsa03022 | 0.19608168 |
| 121 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.19135634 |
| 122 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.17705407 |
| 123 | Peroxisome_Homo sapiens_hsa04146 | 0.17513559 |
| 124 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.16936945 |
| 125 | Endocytosis_Homo sapiens_hsa04144 | 0.15192579 |
| 126 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.14671866 |
| 127 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.13861967 |
| 128 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.13807909 |
| 129 | Parkinsons disease_Homo sapiens_hsa05012 | 0.13693216 |
| 130 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.11713511 |
| 131 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.10364645 |
| 132 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.09546173 |
| 133 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.08237408 |
| 134 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.05348578 |
| 135 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.03983149 |
| 136 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.03364055 |
| 137 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.02763042 |
| 138 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.02575770 |
| 139 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.01625040 |
| 140 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0176136 |

